Draft Guide Helps Speed Generic Psoriasis Cream Approvals
Published Date: 5/21/2025
Notice
Summary
The FDA just released a draft guide to help drug makers test roflumilast cream, a medicine for skin problems. This guide shows how to prove new versions work just as well as the original, making it easier and faster to get approval. If you’re in the drug business, keep an eye out—final rules could speed up your product launches and save money!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Draft FDA Guidance for Roflumilast
The FDA released a draft guidance titled "Draft Guidance on Roflumilast." When finalized, it will provide product-specific recommendations on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for roflumilast topical cream.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in